$23.63
0.632.74%
At Close: -
$23.55
-0.08-0.34%
After Hours: Aug 23, 6:45 PM EDT
15 minutes delayed
Intellia Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Intellia Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $-1.52 | $-1.23 | -23.6 % |
Mar 2024 | 2024-05-09 | $-1.12 | $-1.38 | 18.8 % |
Dec 2023 | 2024-02-22 | $-1.46 | $-1.45 | -0.69 % |
Sep 2023 | 2023-11-09 | $-1.38 | $-1.50 | 8.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-08 | $6.96M | $19.16M | -63.7 % |
Mar 2024 | 2024-05-09 | $28.94M | $11.50M | 151.6 % |
Sep 2023 | 2023-11-09 | $11.99M | $12.45M | -3.68 % |
Jun 2023 | 2023-08-03 | $13.59M | $13.95M | -2.55 % |
Intellia Therapeutics (NTLA) is scheduled to report earnings on November 7, 2024. The last reported earnings were for reported on August 8, 2024 for Q2.
The Actual EPS was $-1.52, which missed the estimate of $-1.23.
The Actual Revenue was $7M, which missed the estimate of $19.2M.
Browse earnings estimates, EPS, and revenue on all stocks.